A 52 week treatment multi center randomized double blind double dummy parallel group active controlled study to compare the effect of QVA149 indacaterol maleate glycopyronium bromide with salmeterol fluticasone on the rate of exacerbations in subjects with moderate to very severe COPD CQVA149A2318